Navigation Links
Fake Drugs Entering the U.S.: Lawyers at Console & Hollawell Highlight Federal Warnings About Counterfeit Medications
Date:12/28/2012

Marlton, NJ (PRWEB) December 28, 2012

Federal regulators are warning more than 350 doctors and medical practices across the country that the Botox they received from a supplier in Canada does not carry federal approval and is most likely counterfeit. The reportedly fake anti-wrinkle drug, shipped by a company owned by Canada Drugs, does not have the approval of the U.S. Food and Drug Administration (FDA) and therefore the agency can’t guarantee its effectiveness or its safety, according to NBC News. The report is the fifth of its kind in 2012 where the FDA issued a warning about drug manufacturers operating outside the country. In New Jersey, injury attorney Richard P. Console Jr. stresses the need for medical professionals to heed these warnings and avoid administering dangerous drugs to patients.

“Healthcare professionals and hospitals have a duty to use approved medications when treating patients,” he said. “Knowingly using a counterfeit drug or failing to inspect medication properly, puts patients at risk for additional injuries and could lead to malpractice actions down the road. Certainly, Botox is no compound to mess around with if you’re not absolutely sure it’s safe.”

The FDA reportedly commented that Canada Drugs has been at the center of shipping of other unapproved or counterfeit medications in 2012. In February, the FDA targeted shipments of the cancer drug Avastin made by Canada Drugs when it warned 19 healthcare providers in the United States of possible counterfeiting. The federal regulator also ordered the shutdown of 4,100 websites later in the year for selling unapproved medications to consumers in the United States, according to published reports. Many of those sites were reportedly operated by agents of Canada Drugs, says NBC News.

Counterfeit drugs may contain dangerous substances that alter the potency of medications, which can lead to higher-strength or ineffective doses. Console, whose firm of medical malpractice attorneys has been helping accident victims obtain compensation since 1994, has seen the dangers of prescription pharmaceuticals in the injuries his clients have suffered.

“Prescription pharmaceuticals are dangerous enough without attempting to use counterfeit copies of approved medications,” he said. “Doctors who try to get away with administering fake or unapproved medications to patients need to be held accountable. The FDA needs to pursue companies that try to make these products available in the United States aggressively, and it appears they’re being proactive. Multiple warnings issued against the same company in a single year would leave me to believe there’s more that could be done to stop the behavior.”

Console & Hollawell P.C. is a personal injury law firm helping victims of medical malpractice in New Jersey. The firm’s attorneys have secured more than $30,000,000 in deserved compensation for their clients, including those affected by deadly prescription drugs.

http://vitals.nbcnews.com/_news/2012/12/24/16128177-fda-warns-doctors-of-counterfeit-botox?lite

Read the full story at http://www.prweb.com/releases/2012/12/prweb10275263.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Pharmacy Robots Linked to Bacterial Contamination of Drugs
2. Penn study cautions use of drugs to block niacin flush
3. Urinary Incontinence Drugs May Be More Trouble Than Theyre Worth
4. Discovery could help to develop drugs for organ transplant and cancer patients
5. Not taking gastroprotective drugs prescribed with anti-inflammatory medicines
6. Live imaging shows response to cancer drugs can be boosted by altering tumor microenvironment
7. Weight-Loss Surgery Beat Drugs for Cutting Diabetes in Very Obese
8. Seniors Stop Taking Heart Drugs In Medicare Donut Hole
9. New Psoriasis Drugs Not Much Better Than Standard Therapy, Study Finds
10. About 1 baby born each hour addicted to opiate drugs in U.S., U-M study shows
11. Blood pressure drugs linked with lower PTSD symptoms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/6/2016)... IL (PRWEB) , ... February 06, 2016 , ... ... recovery phases of eating disorder treatment helps to reduce the frequency and level ... of the Recovery Phase: Re-Establishing Healthy Identity and Purpose,” will explore the critical ...
(Date:2/5/2016)... ... February 05, 2016 , ... Successful recruitment ... new clinical and scientific initiatives have all marked the last 12 months at ... and CEO of the nation’s oldest cancer center, Candace S. Johnson, PhD, outlined ...
(Date:2/5/2016)... ... February 05, 2016 , ... Freed-Hardeman University President Joe ... signed a joint enrollment and degree completion agreement. The agreement, which begins ... degrees at FHU|Dickson. , The agreement allows students to be jointly admitted ...
(Date:2/5/2016)... ... ... The American public tends to feel uncomfortable about drinking recycled waste water ... well water. The recent experience with lead contaminated water in Flint, Michigan, according to ... increasing public acceptance of recycled waste water as drinking water. , The Flint ...
(Date:2/5/2016)... , ... February 05, 2016 , ... At its annual ... Patrick McDermott as Chairman of the National Board of Directors. Mr. McDermott succeeds former ... the Board,” stated Leslie A. Chambers , APDA President and CEO. “Pat has ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... , Feb. 4, 2016 Summary Breast ... cancer and the most common cancer in women worldwide, ... disease exceedingly prevalent. The number of women diagnosed with ... but the number of deaths has declined due to ... treatment has been revolutionized in the past four decades, ...
(Date:2/4/2016)... Feb. 4, 2016 Mettler-Toledo International Inc. (NYSE: ... 2015.  Provided below are the highlights: , ... compared with the prior year.  Reported sales decreased 3% ... quarter. , Net earnings per diluted share as ... prior- year period.  Adjusted EPS was $4.65, an increase ...
(Date:2/4/2016)... 2016  Blueprint Medicines Corporation (NASDAQ: BPMC ... selective investigational kinase medicines for patients with genomically ... board of directors of Lonnel Coats , ... of industry-related experience. Jeffrey Albers ... strong strategic experience developing and commercializing numerous oncology ...
Breaking Medicine Technology: